|
|||||
|
|

Business transformation services company Genpact (NYSE:G) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5.6% year on year to $1.32 billion. On the other hand, next quarter’s revenue guidance of $1.29 billion was less impressive, coming in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.97 per share was 3.8% above analysts’ consensus estimates.
Is now the time to buy G? Find out in our full research report (it’s free for active Edge members).
Genpact delivered a Q4 performance that exceeded Wall Street's expectations, prompting a positive market reaction. Management credited revenue growth to strong demand for advanced technology solutions, particularly in artificial intelligence (AI) and agentic operations, which focus on combining domain-specific AI agents with human expertise. CEO Balkrishan Kalra highlighted the company’s rapid adoption of its AP agentic suite and expanding partnerships with technology providers as key contributors to the quarter’s success, stating, “We are fundamentally reshaping how businesses operate, and we are doing so at speed.”
Looking ahead, Genpact's forward guidance is shaped by expectations for continued momentum in advanced technology solutions and the growing adoption of agentic operations across its client base. Management anticipates further margin expansion and double-digit non-GAAP profit growth, driven by investments in AI talent and product development. CFO Michael Weiner emphasized the company’s focus on higher-value, recurring revenue streams, noting, “Our rapid acceleration in AgenTeq reflects the strong foundation and client trust we have built over the years, as well as our leadership in advancing AI-led transformation.”
Management attributed the quarter’s progress to accelerated demand for AI-driven solutions, successful client transitions to agentic models, and a steady pipeline of large deals.
Genpact’s outlook centers on accelerating demand for AI-enabled transformation, a shift toward recurring revenue models, and ongoing operational efficiency gains.
In the coming quarters, our team will closely monitor (1) the pace of client adoption of advanced technology and agentic solutions, (2) the company’s ability to secure and deliver large-scale transformation deals, and (3) the impact of ongoing investments in AI talent and partnerships on both revenue mix and margin expansion. Additionally, the execution of Genpact’s product roadmap and successful integration of AI with domain expertise will be critical benchmarks.
Genpact currently trades at $38.50, up from $37.70 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
| Apr-29 | |
| Apr-28 | |
| Apr-23 | |
| Apr-11 | |
| Apr-09 | |
| Apr-08 | |
| Mar-26 | |
| Mar-23 | |
| Mar-10 | |
| Mar-05 | |
| Mar-04 | |
| Mar-02 | |
| Mar-02 | |
| Feb-28 | |
| Feb-27 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite